GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹3,744 Cr | ₹3,051 Cr | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr |
What is the latest Trade Payables ratio of GLENMARK PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹3,744 Cr |
| Mar2025 | ₹3,051 Cr |
| Mar2024 | ₹2,536 Cr |
| Mar2023 | ₹2,000 Cr |
| Mar2022 | ₹2,289 Cr |
How is Trade Payables of GLENMARK PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,744 Cr | 22.70 | |
| Mar2025 | ₹3,051 Cr | 20.32 | |
| Mar2024 | ₹2,536 Cr | 26.77 | |
| Mar2023 | ₹2,000 Cr | -12.59 | |
| Mar2022 | ₹2,289 Cr | - | |
Compare Trade Payables of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹68,489.9 Cr | -2.5% | 5.6% | 27.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.5% |
5.6% |
27.5% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses